EP3623386
ÖRVANDI TNF-VIÐTAKABINDIEFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.1.2016EP published:
13.4.2022EP application number:
19194817.3
EP translation filed:
27.6.2022Grant published:
15.8.2022EPO information:
European Patent Register
Max expiry date:
7.1.2036Expiry date:
7.1.2027Next due date:
31.1.2027
Title in English:
AGONISTIC TNF RECEPTOR BINDING AGENTSLanguage of the patent:
English
Timeline
Today
8.1.2016EP application
13.4.2022EP Publication
27.6.2022Translation submitted
15.8.2022Registration published
7.1.2027Expires
Owner
Name:
BioNTech SEAddress:
An der Goldgrube 12, 55131 Mainz, DE
Name:
Genmab A/SAddress:
Kalvebod Brygge 43, 1560 Copenhagen V, DK
Inventor
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Name:
GIESEKE, FriederikeAddress:
55116 Mainz, DE
Name:
ALTINTAS, IsilAddress:
3584 CM Utrecht, NL
Name:
SATIJN, DavidAddress:
3584 Utrecht, NL
Name:
PARREN, PaulAddress:
3584 CM Utrecht, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2015/050255Date:
8.1.2015Country:
WO
Classification
Categories:
C07K 16/28, C07K 16/46
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 19.1.2023
Expires: 7.1.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 18.1.2024
Expires: 7.1.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 20.1.2025
Expires: 7.1.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 21.1.2026
Expires: 7.1.2027
Payer: Árnason Faktor ehf.